Celebrating Milestones with Hope: The 100th Sign-Up for the Synovial Sarcoma Registry and Biospecimen Repository
We are thrilled to announce a significant milestone for the Synovial Sarcoma Registry and Biospecimen Repository, as we proudly welcome…
A New Cell Therapy Approach Advances Toward Clinical Testing in Synovial Sarcoma
Zelluna, a Norway-based biotechnology company, has announced the submission of a Clinical Trial Application (CTA) in the United Kingdom for…
Synovial Sarcoma Foundation Welcomes Julie Kramer as Community Engagement & Partnerships Manager
Current Patient to Drive Relationships and Support for the Synovial Sarcoma Community [Philadelphia, PA] – 12/12/25 – The Synovial Sarcoma…
Arizona Pioneers New Immune Therapy for Synovial Sarcoma Treatment
In a groundbreaking advancement in cancer treatment, a patient with synovial sarcoma in Arizona has become the first in the…
Revolutionary Insights Unveiled in Latest Synovial Sarcoma Research
A landmark study just published in Nature Communications finally pinpointed the exact “cell of origin” for synovial sarcoma — a rare, primitive…
2025 Connective Tissue Oncology Society
The Synovial Sarcoma Foundation is excited to share that we are on site this week at the 2025 Connective Tissue Oncology Society…
Rise in Early-Onset Cancers: More Diagnoses, Not Always More Disease
Not every detected cancer is clinically meaningful. For younger patients, especially, this can mean confronting a diagnosis that may never…
Dr. Theodore W. Laetsch, Synovial Sarcoma Foundation Board Member, Receives $1 Million Grant to Advance Rare Tumor Studies
The Synovial Sarcoma Foundation is pleased to highlight a significant milestone at the Children’s Hospital of Philadelphia (CHOP), where pediatric…
Innovative Approach Shows Promise Against Synovial Sarcoma Using Protein-Blocking Drugs
The Synovial Sarcoma Foundation is dedicated to supporting cutting-edge research that advances treatment options for this rare and aggressive cancer.…